Schranz Jennifer 4
4 · Nabriva Therapeutics plc · Filed Feb 4, 2020
Insider Transaction Report
Form 4
Schranz Jennifer
Chief Medical Officer
Transactions
- Tax Payment
Ordinary Shares
2020-01-31$1.35/sh−4,295$5,798→ 53,705 total
Holdings
- 58,000
Ordinary Shares
Footnotes (1)
- [F1]The reporting person has reported prior awards of restricted stock units in Table II of Form 4. The total reported in Column 5 includes 52,500 previously reported restricted stock units and 5,500 ordinary shares.